FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386562983> ?p ?o ?g. }

• W4386562983 abstract "Introduction Tumor-initiating cells (TICs) are rare, stem-like, and highly malignant. Although intravenous hepatitis B and C immunoglobulins have been used for HBV and HCV neutralization in patients, their tumor-inhibitory effects have not yet been examined. Hepatitis B immunoglobulin (HBIG) therapy is employed to reduce hepatocellular carcinoma (HCC) recurrence in patients after living donor liver transplantations (LDLT). Hypothesis We hypothesized that patient-derived intravenous immunoglobulin (IVIG) binding to HCC associated TICs will reduce self-renewal and cell viability driven by β-CATENIN-downstream pathways. β-CATENIN activity protected TICs from IVIG effects. Methods The effects of HBIG and HCIG binding to TICs were evaluated for cell viability and self-renewal. Results Inhibition of β-CATENIN pathway(s) augmented TIC susceptibility to HBIG- and HCIG-immunotherapy. HBV X protein (HBx) upregulates both β-CATENIN and NANOG expression. The co-expression of constitutively active β-CATENIN with NANOG promotes self-renewal ability and tumor-initiating ability of hepatoblasts. HBIG bound to HBV+ cells led to growth inhibition in a TIC subset that expressed hepatitis B surface antigen. The HBx protein transformed cells through β-CATENIN-inducible lncRNAs EGLN3-AS1 and lnc-β-CatM . Co-expression of constitutively active β-CATENIN with NANOG promoted self-renewal ability of TICs through EGLN3 induction. β-CATENIN-induced lncRNAs stabilized HIF2 to maintain self-renewal of TICs. Targeting of EGLN3-AS1 resulted in destabilization of EZH2-dependent β-CATENIN activity and synergized cell-killing of TICs by HBIG or HCIG immunotherapy. Discussion Taken together, WNT and stemness pathways induced HIF2 of TICs via cooperating lncRNAs resulting in resistance to cancer immunotherapy. Therefore, therapeutic use of IVIG may suppress tumor recurrence through inhibition of TICs." @default.
• W4386562983 created "2023-09-10" @default.
• W4386562983 creator A5009910426 @default.
• W4386562983 creator A5023365954 @default.
• W4386562983 creator A5024163625 @default.
• W4386562983 creator A5033094637 @default.
• W4386562983 creator A5040427012 @default.
• W4386562983 creator A5051190667 @default.
• W4386562983 creator A5054530106 @default.
• W4386562983 creator A5057059496 @default.
• W4386562983 creator A5065387885 @default.
• W4386562983 creator A5068778977 @default.
• W4386562983 creator A5070288633 @default.
• W4386562983 creator A5088710046 @default.
• W4386562983 creator A5092830648 @default.
• W4386562983 date "2023-09-08" @default.
• W4386562983 modified "2023-10-17" @default.
• W4386562983 title "β-CATENIN stabilizes HIF2 through lncRNA and inhibits intravenous immunoglobulin immunotherapy" @default.
• W4386562983 cites W1498931318 @default.
• W4386562983 cites W1549431657 @default.
• W4386562983 cites W1573044060 @default.
• W4386562983 cites W1595395115 @default.
• W4386562983 cites W1970246059 @default.
• W4386562983 cites W1973279069 @default.
• W4386562983 cites W1973346087 @default.
• W4386562983 cites W1973392006 @default.
• W4386562983 cites W2005868568 @default.
• W4386562983 cites W2007601283 @default.
• W4386562983 cites W2011121500 @default.
• W4386562983 cites W2015954989 @default.
• W4386562983 cites W2016160962 @default.
• W4386562983 cites W2017575850 @default.
• W4386562983 cites W2018282034 @default.
• W4386562983 cites W2026211487 @default.
• W4386562983 cites W2030649728 @default.
• W4386562983 cites W2039994523 @default.
• W4386562983 cites W2055343568 @default.
• W4386562983 cites W2077675724 @default.
• W4386562983 cites W2085039090 @default.
• W4386562983 cites W2088629624 @default.
• W4386562983 cites W2101538557 @default.
• W4386562983 cites W2106448791 @default.
• W4386562983 cites W2112350806 @default.
• W4386562983 cites W2117532914 @default.
• W4386562983 cites W2133370909 @default.
• W4386562983 cites W2142046859 @default.
• W4386562983 cites W2164938105 @default.
• W4386562983 cites W2166932492 @default.
• W4386562983 cites W2168472139 @default.
• W4386562983 cites W2191128990 @default.
• W4386562983 cites W2198606871 @default.
• W4386562983 cites W2203341275 @default.
• W4386562983 cites W2315027248 @default.
• W4386562983 cites W2321802291 @default.
• W4386562983 cites W2396961098 @default.
• W4386562983 cites W2419277740 @default.
• W4386562983 cites W2528379500 @default.
• W4386562983 cites W2591717879 @default.
• W4386562983 cites W2597872842 @default.
• W4386562983 cites W2780852610 @default.
• W4386562983 cites W2788119193 @default.
• W4386562983 cites W2908556939 @default.
• W4386562983 cites W3036121967 @default.
• W4386562983 cites W3082857338 @default.
• W4386562983 cites W3134537286 @default.
• W4386562983 cites W4211107801 @default.
• W4386562983 doi "https://doi.org/10.3389/fimmu.2023.1204907" @default.
• W4386562983 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37744383" @default.
• W4386562983 hasPublicationYear "2023" @default.
• W4386562983 type Work @default.
• W4386562983 citedByCount "0" @default.
• W4386562983 crossrefType "journal-article" @default.
• W4386562983 hasAuthorship W4386562983A5009910426 @default.
• W4386562983 hasAuthorship W4386562983A5023365954 @default.
• W4386562983 hasAuthorship W4386562983A5024163625 @default.
• W4386562983 hasAuthorship W4386562983A5033094637 @default.
• W4386562983 hasAuthorship W4386562983A5040427012 @default.
• W4386562983 hasAuthorship W4386562983A5051190667 @default.
• W4386562983 hasAuthorship W4386562983A5054530106 @default.
• W4386562983 hasAuthorship W4386562983A5057059496 @default.
• W4386562983 hasAuthorship W4386562983A5065387885 @default.
• W4386562983 hasAuthorship W4386562983A5068778977 @default.
• W4386562983 hasAuthorship W4386562983A5070288633 @default.
• W4386562983 hasAuthorship W4386562983A5088710046 @default.
• W4386562983 hasAuthorship W4386562983A5092830648 @default.
• W4386562983 hasBestOaLocation W43865629831 @default.
• W4386562983 hasConcept C104317684 @default.
• W4386562983 hasConcept C107459253 @default.
• W4386562983 hasConcept C137620995 @default.
• W4386562983 hasConcept C145103041 @default.
• W4386562983 hasConcept C159654299 @default.
• W4386562983 hasConcept C203014093 @default.
• W4386562983 hasConcept C207701140 @default.
• W4386562983 hasConcept C2522874641 @default.
• W4386562983 hasConcept C2777701055 @default.
• W4386562983 hasConcept C2780593183 @default.
• W4386562983 hasConcept C30145163 @default.
• W4386562983 hasConcept C502942594 @default.
• W4386562983 hasConcept C55493867 @default.
• W4386562983 hasConcept C62478195 @default.

• next